Claim Missing Document
Check
Articles

Found 2 Documents
Search

The Structured Innovation System: Optimizing Patent Filing and Obtaining Global Protection Raymond R. Tjandrawinata; Henry Soelistyo Budi
Journal of World Science Vol. 4 No. 3 (2025): Journal of World Science
Publisher : Riviera Publishing

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58344/jws.v4i3.1373

Abstract

Intellectual property (IP) is a key component of the global economy, and it is also a critical component of ensuring global competitiveness. It is essential for organizations and inventors seeking robust global intellectual property protection to maintain competitive advantage. This study examines the role of structured innovation in enhancing patent approval rates, mitigating legal risks, and accelerating market entry for technological innovations. The study employs a mixed-methods approach, integrating legal analysis, case study evaluations, empirical data collection, and AI-based predictive modeling to provide an in-depth understanding of the factors contributing to successful patent filings and long-term intellectual property sustainability. The research also examines emerging trends in artificial intelligence and predictive analytics that are reshaping the landscape of IP management. The findings derived from this study serve as a valuable resource for policymakers, legal practitioners, and industry stakeholders seeking to enhance their innovation strategies in an increasingly competitive and complex intellectual property landscape. Specifically, this study aims to provide a strategic roadmap for optimizing patent filing and securing global protection by evaluating real-world applications and examining cross-jurisdictional intellectual property frameworks. A comparative study of patent laws across key jurisdictions, including the United States, the European Union, and China, highlights critical differences in examination procedures, enforceability, and litigation risks, providing comparative insights essential for businesses operating in global markets. The empirical findings underscore that structured innovation methodologies contribute to higher patent success rates and reduce legal uncertainties, enforcement complexities, and post-grant challenges.
Transformation of Patent Policy in Indonesia: New Opportunities and Challenges for Pharmaceutical Innovation in the Digital Era Raymond R. Tjandrawinata; Henry Soelistyo Budi
Interdiciplinary Journal and Hummanity (INJURITY) Vol. 4 No. 3 (2025): INJURITY: Journal of Interdisciplinary Studies.
Publisher : Pusat Publikasi Nusantara

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58631/injurity.v4i3.1415

Abstract

Indonesia is a developing country with an expanding healthcare market, which faces the enduring challenge of fostering a pharmaceutical patent system that incentivizes research and development while ensuring broad access to affordable medicines. This study aims to offer policy recommendations that balance the need for pharmaceutical innovation with the imperative of maintaining an accessible and competitive healthcare landscape. The study includes a review of pharmaceutical patent regulations in India, Brazil, the United States, and the European Union. It integrates empirical data analysis to assess patent application trends and market dynamics, utilizing a difference-in-differences econometric model to establish causality between policy reforms and sector changes. It highlights the necessity of public health safeguards, proposing mechanisms like conditional compulsory licensing as critical elements in the patent reform framework. The study emphasizes actionable policy recommendations while incorporating stakeholder perspectives from regulatory authorities, pharmaceutical firms, and public health organizations to understand the implications for investment, competition, and medicine accessibility. By implementing these strategic policy adjustments, Indonesia can maximize the benefits of Law No. 65 of 2024 while safeguarding public health and promoting domestic pharmaceutical innovation in a rapidly evolving global landscape.